Allan Tsung, MD, has been appointed director of the Division of Surgical Oncology, a key clinical and research leadership role at both The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) and the Ohio State University College of Medicine. His appointment is effective Jan. 1, 2019.
Tsung currently is the Raizman-Haney Endowed Chair and professor of surgery at the University of Pittsburgh Medical Center (UPMC), where he has served on faculty since 2008. During his time at UPMC, Tsung served as director of the liver cancer program at the UPMC Hillman Cancer Center and led the UPMC Regional Therapy Program for primary and metastatic liver cancers. He also held many leadership roles related to research and education, including director for the Biospecimen Repository and Processing Core of the Pittsburgh Liver Research Center and vice chair of research for the UPMC Department of Surgery.
An expert in laparoscopic and robotic surgery techniques, Tsung’s clinical interests focus on evaluating and managing patients with liver, bile duct and pancreas cancers.
“Allan is a nationally respected surgeon and scientist, so we are thrilled to have him join our cancer center to bring this expertise to serve patients in central Ohio and beyond,” says Raphael Pollock, MD, PhD, director of The Ohio State University Comprehensive Cancer Center.
Tsung brings a prolific research laboratory to Ohio State focused on understanding how inflammatory responses alter the local microenvironment, leading to cancer progression via tumor cell survival, expansion and metastases. Current research projects focus on molecular markers in the diagnosis and clinical management of hepatobiliary and pancreas cancers as well as health services research focusing on improving the access, delivery and quality of surgical oncology care.
Tsung’s work has generated more than 170 published peer-reviewed manuscripts in leading scientific journals and has culminated in two current principal investigator R01 grants from the National Institutes of Health (NIH), multiple co-investigator R01s and a number of society and institutional grants.
Tsung received his medical degree from SUNY Health Science Center at Brooklyn. He completed a surgical internship, a surgical residency, a surgical research fellowship and a hepatobiliary and pancreas surgery fellowship, all at the University of Pittsburgh. He participated in the Marshall Webster Physician Leadership Program at the Katz Graduate School of Business and the Society of University Surgeons Leadership Agility Program at Northwestern University’s Kellogg School of Management.
A nationally recognized leader in surgical oncology, Tsung is the current president of the Society of University Surgeons and holds additional leadership roles with the Society of Surgical Oncology, Society of Asian Academic Surgeons, the Americas Hepato-Pancreato-Biliary Association and the American Association for the Study of Liver Diseases.
To learn more about the gastrointestinal cancer research and treatment teams at the OSUCCC – James, visit cancer.osu.edu.
About the OSUCCC – James
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 49 National Cancer Institute-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs. As the cancer program’s 308-bed adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet® designation, the highest honor an organization can receive for quality patient care and professional nursing practice. At 21 floors with more than 1.1 million square feet, The James is a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care. For more information, visit cancer.osu.edu.
Amanda J. Harper
OSUCCC – James Media Relations